Tudor Investment Corp’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-39,764
Closed -$1.41M 1540
2023
Q4
$1.41M Buy
39,764
+6,764
+20% +$241K 0.01% 827
2023
Q3
$981K Buy
33,000
+5,972
+22% +$178K 0.01% 915
2023
Q2
$487K Buy
+27,028
New +$487K 0.01% 1145
2022
Q4
Sell
-26,753
Closed -$525K 1633
2022
Q3
$525K Buy
+26,753
New +$525K 0.01% 1085